Roche Holding AG (XSWX:RO) Cash Flow from Investing: CHF-7,957 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:RO Roche Holding AG XSWX:RO
77 GF Score
Price CHF372.60
GF Value CHF271.99
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Roche Holding AG Cash Flow from Investing?

Roche Holding AG XSWX:RO +1.14% 77 Cash Flow from Investing is CHF-7,957 Mil as of Jun. 2026. GuruFocus rates XSWX:RO with a GF Score™ of 77/100 and a GF Value™ of CHF271.99 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).

For the six months ended in Jun. 2026, Roche Holding AG spent CHF1,570 Mil on purchasing property, plant, equipment. It gained CHF20 Mil from selling property, plant, and equipment. It spent CHF268 Mil on purchasing business. It gained CHF0 Mil from selling business. It spent CHF166 Mil on purchasing investments. It gained CHF5,727 Mil from selling investments. It paid CHF1,301Mil for net Intangibles purchase and sale. And it paid CHF23 Mil for other investing activities. In all, Roche Holding AG gained CHF2,419 Mil on investment activities in financial market and operating subsidiaries for the six months ended in Jun. 2026.


Roche Holding AG  (XSWX:RO) Cash Flow from Investing Explanation

Cash flow from investing contains nine items:

1. Purchase Of Property, Plant, Equipment:
Purchase of PPE indicates the amount used to purchase property, plant, and equipment.

Roche Holding AG's purchase of property, plant, equipment for the six months ended in Jun. 2026 was CHF-1,570 Mil. It means Roche Holding AG spent CHF1,570 Mil on purchasing property, plant, equipment.

In the capital spending for property, plant and equipment (PPE), some part of spending may be from the expansion of business. The business needs more property, plant and equipment (PPE) as it grows. Another part may be from replacement of the property, plant and equipment (PPE) of existing business. For some companies, the cash spent on replacing of the property, plant and equipment (PPE) of the existing business will be close to the depreciation of property, plant and equipment (PPE) reported in the income statement.

In Warren Buffett's definition of Owner's Earnings, he deducts the estimate of the cost of replacing the property, plant and equipment (PPE) of the existing business from cash flow from operations. The cash spent on the new property, plant, and equipment is not deducted. The reason is because these are not costs of the existing business. In his 1986 letter to shareholders, Warren Buffett wrote this about owner earnings:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume....Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

2. Sale Of Property, Plant, Equipment:
Sale of PPE indicates the amount gained from selling property, plant, and equipment.

Roche Holding AG's sale of property, plant, equipment for the six months ended in Jun. 2026 was CHF20 Mil. It means Roche Holding AG gained CHF20 Mil from selling property, plant, and equipment.

3.Purchase Of Business:
Purchase of business indicates the amount used to purchase business.

Roche Holding AG's purchase of business for the six months ended in Jun. 2026 was CHF-268 Mil. It means Roche Holding AG spent CHF268 Mil on purchasing business.

4. Sale Of Business:
Sale of business indicates the amount gained from selling business.

Roche Holding AG's sale of business for the six months ended in Jun. 2026 was CHF0 Mil. It means Roche Holding AG gained CHF0 Mil from selling business.

5. Purchase Of Investment:
Purchase of Investments represents cash outflow on the purchase of investments in securities.

Roche Holding AG's purchase of investment for the six months ended in Jun. 2026 was CHF-166 Mil. It means Roche Holding AG spent {stock_data.stock.currency_symbol}}166 Mil on purchasing investments.

6. Sale Of Investment:
Sale of Investments represents cash inflow on the sale of investments in securities.

Roche Holding AG's sale of investment for the six months ended in Jun. 2026 was CHF5,727 Mil. It means Roche Holding AG gained CHF5,727 Mil from selling investments.

7. Net Intangibles Purchase And Sale:
Net Intangibles purchase and sale means the net cash inflow received by a company that comes from the purchase and sale of intangibles. It equals the cash received from sale of intangibles minus the cash spent on purchasing intangibles.

Roche Holding AG's net Intangibles purchase and sale for the six months ended in Jun. 2026 was CHF-1,301 Mil. It means Roche Holding AG paid CHF1,301 Mil for net Intangibles purchase and sale.

8. Cash From Discontinued Investing Activities:
Cash from discontinued investing activities means the cash received by a company that comes from the discontinued investing activities.

Roche Holding AG's cash from discontinued investing activities for the six months ended in Jun. 2026 was 0 Mil. It means Roche Holding AG paid CHF0 Mil for discontinued investing activities.

9. Cash From Other Investing Activities:
Cash from other investing activities means the cash received by a company that comes from other investing activities.

Roche Holding AG's cash from other investing activities for the six months ended in Jun. 2026 was CHF-23 Mil. It means Roche Holding AG paid CHF23 Mil for other investing activities.


Roche Holding AG Cash Flow from Investing Related Terms


Roche Holding AG Cash Flow from Investing Historical Data

* Premium members only.

The historical data trend for Roche Holding AG's Cash Flow from Investing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Roche Holding AG Cash Flow from Investing Chart

Roche Holding AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow from Investing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6,552.00 -2,924.00 -10,643.00 -11,393.00 -8,543.00

Roche Holding AG Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Cash Flow from Investing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2,865.00 -8,528.00 1,833.00 -10,376.00 2,419.00
XSWX:RO
77GF Score
Roche Holding AG XSWX:RO
Cash Flow from Investing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Roche Holding AG Cash Flow from Investing Calculation

Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).

If a company spends cash on property, plant and equipment (PPE), this will reduce their cash position. This is called Capital Expenditures (CPEX).

Likewise, if a company buys another company for cash, this will reduce their cash position.

Roche Holding AG's Cash Flow from Investing for the fiscal year that ended in Dec. 2025 is calculated as:

Roche Holding AG's Cash Flow from Investing for the quarter that ended in Jun. 2026 is calculated as:


Cash Flow from Investing for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF-7,957 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow from Investing of CHF-7,957 Mil mean?
Roche Holding AG (XSWX:RO) has a Cash Flow from Investing of CHF-7,957 Mil as of Jun. 2026. Cash Flow from Investing is the amount of cash earned or paid from investing operations. View historical data for Roche Holding AG and its competitors.
Is Roche Holding AG's Cash Flow from Investing too high?
Roche Holding AG's current Cash Flow from Investing is CHF-7,957 Mil. Overall, Roche Holding AG has a GF Score™ of 77/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Roche Holding AG's Cash Flow from Investing compare to LLY and JNJ?
Roche Holding AG's Cash Flow from Investing of CHF-7,957 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow from Investing for a Drug Manufacturers company?
A good Cash Flow from Investing depends on the Drug Manufacturers industry context. However, Cash Flow from Investing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow from Investing mean?
A high Cash Flow from Investing can signal that a stock is expensive relative to its fundamentals. Cash Flow from Investing is the amount of cash earned or paid from investing operations. View historical data for Roche Holding AG and its competitors. Roche Holding AG's current Cash Flow from Investing is CHF-7,957 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Roche Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Roche Holding AG (XSWX:RO) is currently considered Significantly Overvalued. The stock's GF Value™ is CHF271.99, compared to a current price of CHF372.60 — trading 37% above its estimated fair value. The current Cash Flow from Investing is CHF-7,957 Mil. Roche Holding AG's overall GF Score™ is 77/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow from Investing calculated?
Cash Flow from Investing is calculated from a company's financial statements. For Roche Holding AG (XSWX:RO), the current Cash Flow from Investing is CHF-7,957 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Roche Holding AG (XSWX:RO) Overvalued in 2026?

Based on GuruFocus' analysis, Roche Holding AG stock appears to be overvalued. The current stock price of CHF372.60 is trading 37% above its estimated GF Value™ of CHF271.99. GuruFocus considers Roche Holding AG to be Significantly Overvalued.

Key valuation signals for XSWX:RO:

  • Cash Flow from Investing: CHF-7,957 Mil
  • GF Value™: CHF271.99 vs. price of CHF372.60 (37% above fair value)
  • GF Score™: 77/100 with 7 warning signs

No single metric tells the full story. See the XSWX:RO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Roche Holding AG Business Description

Address Grenzacherstrasse 124, Basel, CHE, 4070
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 40% of pharmaceutical sales, and centralized and point-of-care diagnostics for two-thirds of diagnostic-related sales.
77GF Score

Get the complete analysis for XSWX:RO

Cash Flow from Investing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF372.60
Price
CHF271.99
GF Value